Pharmacology · Antidiabetic Drugs (Oral Hypoglycemics, Insulins)

A patient with type 2 diabetes on metformin and glimepiride has HbA1c of 8.8% and postprandial glucose excursions of 280 mg/dL. Acarbose is added. The glucose-lowering effect of acarbose is primarily due to inhibition of which enzyme?

  • A Alpha-glucosidase on the brush border of the small intestine
  • B Alpha-amylase in pancreatic secretions
  • C SGLT1 transporter in the proximal small intestine
  • D Dipeptidyl peptidase-4 in the intestinal endothelium
Correct answer: A. Alpha-glucosidase on the brush border of the small intestine

Explanation

Acarbose is an alpha-glucosidase inhibitor that delays carbohydrate digestion at the intestinal brush border, reducing postprandial glucose peaks. It does not inhibit pancreatic alpha-amylase as its primary target (B). SGLT1 inhibition (C) is not its mechanism. DPP-4 inhibition (D) is the action of gliptins.

Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs

See all Antidiabetic Drugs (Oral Hypoglycemics, Insulins) MCQs →